Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and national direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.…
Retractable Technologies, Inc. Results for the Periods Ended September 30, 2026
Retractable Technologies (NYSEAMERICAN: RVP) is listed on NYSE American, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 195 employees.
The shares were at 0.5580 USD on 20 November 2026, down 34.4% over 52 weeks. Its 52-week range is 0.5300 USD to 0.8700 USD: the price is 35.9% below the high and 5.3% above the low.
Its market capitalisation is 16.70M USD.
Retractable Technologies reports return on equity of -16.9%, an operating margin of -58.5% and revenue up 40.1% year over year.
It holds more cash than debt, a net cash position of 38.62M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.